The shares of the prominent agrochemical manufacturer hit 5 percent upper circuit in today’s trading session after the company bagged significant order from National Fertilizers Limited worth Rs 8.60 crore.
With a market capitalization of Rs 88 crore, the shares of Aristo Bio-Tech & Lifescience Ltd were trading at Rs 130.15 per share, increasing at 4.92 percent as compared to the previous closing price of Rs 124.05 apiece.
The shares of Aristo Bio-Tech & Lifescience Ltd have seen positive movement after bagging a significant order from National Fertilizers Limited worth Rs 8.60 crore for the supply of various Agrochemicals. The order should be executed by September 30, 2025.
Looking forward to the company’s financial performance, revenue decreased by 51 percent from Rs 214 crore in H1FY25 to Rs 104 crore in H2FY25. Further, during the same time frame, net profit turned into a loss from a profit of Rs 5 crore to a loss of Rs 0.49 crore.
Also read: 2 Stocks to buy now for an upside of up to 29%; Recommended by Trade Brains Portal
Aristo Bio-Tech and Lifescience Limited is engaged in providing, manufacturing, formulation, supply, and packaging job work services for various pesticides: insecticides, herbicides, fungicides, plant growth regulators, and a wide variety of other agrochemicals in India as well as for export.
Aristo Bio-Tech and Lifescience Limited serve both domestic and export markets, it offer high-quality packaging services. Its modern facility, located in Vadodara, Gujarat, features advanced equipment for quality control, manufacturing, and packaging of agrochemical products.
Aristo Bio-Tech and Lifescience Limited collaborate with a diverse group of reputed business associates to strengthen their agrochemical network. Key partners include Sinochem, NFL, Astir Agri Chem, Jubilant Agri, Forward Group, and Rotam. These strategic alliances enhance Aristo’s global reach, technology exchange, and product offerings in crop protection and agricultural solutions.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
